?1 adrenoceptor antibodies induce myocardial apoptosis via inhibiting PGC-1?-related pathway.
Ontology highlight
ABSTRACT: BACKGROUND:Peripartum cardiomyopathy (PPCM) is life-threatening heart disease. However, the causes and pathogenesis of PPCM remain unclear. Previous studies found that ?1 adrenoceptor antibodies (?1AA) had possible involvement in the development of PPCM. In the present study, we determined the potential relationship between PPCM and ?1AA, including the mechanism of ?1AA leading to PPCM. METHODS:We extracted the ?1AA from the postpartum Wistar rats that were injected by the antigen peptide segment of the ?1 adrenoceptor to produce PPCM. We tested the effects of ?1AA on H9C2 cell line by CCK-8, LDH, TUNEL, SA-ELISA, qRT-PCR, and western blot methods. Furthermore, PGC-1? was overexpressed to rescue the effect of ?1AA on H9C2 cells. RESULTS:We found that the extracted ?1AA induced apoptosis of cardiac myocytes of H9C2 cell line. Moreover, the expression of peroxisome proliferator-activated receptor ? coactivator-1? (PGC-1?), which is a master regulator of mitochondrial metabolism, and its downstream transcript vascular endothelial growth factor (VEGF) got decreased in H9C2 cells after ?1AA treatment. In addition, the effect of ?1AA could be inhibited by atenolol, the antagonist of ?1 adrenoceptors (?1AR) and imitated by isoprenaline, the agonist of ?1AR. Furthermore, overexpression of PGC-1? in the H9C2 cells rescued the apoptosis of cells and inhibitory expression of VEGF induced by ?1AA. CONCLUSIONS:Our results suggest that the symptoms of PPCM due to myocardial cell apoptosis induced by ?1AA inhibiting the PGC-1?-related pathway impairs mitochondrial energy metabolism. Therefore, our results uncover a previously unknown role of the ?1AA pathway in the etiology of PPCM and provide a novel potential target for the treatment of PPCM.
SUBMITTER: Shi L
PROVIDER: S-EPMC7275518 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA